Press "Enter" to skip to content

Aurobindo Pharma lines up $200 million capex for FY20

The city-based drug maker spent USD 225 million on capex last year and R&D expenditure was at Rs 872 crore or 4.5 per cent of the revenues for the year, he said.

Original source: https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-lines-up-200-million-capex-for-fy20/69811234?utm_source=RSS&utm_medium=ETRSS

Also Read:   Health activist’s question on generic drugs leaves gynaecologists stumped